Tryp Therapeutics Inc (TSE:TRYP) has released an update.
Tryp Therapeutics, Inc. has been acquired by Exopharm Limited through an all-stock transaction, as the plan of arrangement has been finalized, allowing Tryp shareholders to exchange each of their shares for 3.616 Exopharm shares. Following the arrangement, Tryp will be delisted from the Canadian Securities Exchange and will stop trading on the OTCQB Venture Market. Exopharm shares are set to begin trading on the Australian Securities Exchange under the new name ‘Tryptamine Therapeutics Limited’ with the ticker ‘TYP’.
For further insights into TSE:TRYP stock, check out TipRanks’ Stock Analysis page.
